Myeloma Panel By Flowcytometry - Bone Marrow

Also known as: Myeloma Panel by Flow Cytometry, EDTA Bone Marrow**

50+ booked in last 3 days

No special precautions

Sample Type

Blood

Recommended for

Male, Female

Report

Within 24 Hours

Blood test at Home

NABL & CAP Accredited Labs

Accurate & Quality Test Reports

Trusted by Leading Doctors & Hospitals

Overview

The expressions of CD38, CD56, CD19, and CD45 protein markers help identify the composition and function of cells within the bone marrow. The "Myeloma panel by flow cytometry, Bone marrow" test involves analyzing specific parameters in bone marrow samples using flow cytometry. The clinical utility of this test lies in the evaluation of various markers, including CD38, CD56, CD19, CD45, Kappa, and Lambda. By measuring these six parameters, the test helps in the diagnosis and monitoring of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. CD38 is a marker commonly expressed on myeloma cells, while CD56 may indicate an aggressive form of the disease. CD19 and CD45 help identify other cell types present in the sample, and Kappa and Lambda are used to assess the presence of abnormal plasma cells and determine the light chain restriction. This comprehensive panel aids healthcare professionals in accurate disease detection, classification, and treatment planning for patients with multiple myeloma.

Myeloma Panel by Flow Cytometry, EDTA Bone Marrow** Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Myeloma Panel by Flow Cytometry, EDTA Bone Marrow** with a clear pricing structure.

The Myeloma Panel by Flow Cytometry, EDTA Bone Marrow** Price in Mumbai is ₹ 9,750 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

What does the Myeloma Panel measure?

This test analyzes specific proteins (CD38, CD56, CD19, CD45) and the presence of abnormal plasma cells (Kappa, and Lambda) in the bone marrow.

Why is the Myeloma Panel done?

• To diagnose multiple myeloma and determine its stage • To monitor the progression or response to treatment of multiple myeloma • To assess the risk of developing multiple myeloma in high-risk individuals • To differentiate multiple myeloma from other similar conditions or diseases affecting the bone marrow

When is Myeloma Panel recommended and who should take the test?

This test may be recommended if you • are experiencing symptoms such as bone pain, fatigue, recurrent infections, or unexplained weight loss, • have abnormal blood tests suggesting multiple myeloma, • have a family history of multiple myeloma, or • are at high risk for developing multiple myeloma due to certain genetic conditions or prior exposure to radiation or chemicals.

What if the results of the Myeloma Panel are abnormal?

Abnormal results may indicate the presence of multiple myeloma or other plasma cell disorders.

What to expect during the Myeloma Panel - Bone Marrow?

A healthcare professional will draw a small amount of bone marrow from your hip bone using a needle after giving you local anesthesia. They will send the sample to the laboratory for analysis using flow cytometry.

What preparations are required before the Myeloma Panel?

• Inform your doctor about any medications you are taking. Also, tell them if you have any specific requirements. • Follow any fasting instructions given by your doctor. • Some medications may need to be temporarily stopped before the test (as advised by your doctor).

What other tests may be ordered with Myeloma Panel?

• Serum protein electrophoresis (SPEP) and immunofixation electrophoresis (IFE): These blood tests help identify abnormal proteins produced by multiple myeloma. • Complete blood count (CBC): This test evaluates the overall health of your blood cells. • Urine tests: These tests detect abnormal proteins (Bence Jones proteins) in the urine.

What is the Myeloma Panel - Bone Marrow also known as?

Bone Marrow Flow Cytometry for Multiple Myeloma

What is multiple myeloma?

Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell in the bone marrow. It leads to the overproduction of abnormal plasma cells, which can crowd out healthy blood cells and cause various complications. Symptoms may include bone pain, fatigue, recurrent infections, and unexplained weight loss.

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.